ENPP2在肥胖和妊娠小鼠胰岛β细胞中共同上调,且对肥胖期间β细胞代偿至关重要
该研究通过单细胞RNA测序比较饮食诱导肥胖小鼠和妊娠小鼠胰岛细胞,发现ENPP2在两种状态下β细胞中共同上调,且妊娠时升高更显著。功能实验表明ENPP2通过LPA-Akt/mTOR通路促进β细胞增殖、抑制凋亡并增强高糖刺激的胰岛素分泌;Enpp2敲除小鼠高脂饮食下β细胞代偿不足,而ENPP2在糖尿病模型和2型糖尿病患者中表达降低。
要点
- ENPP2在肥胖和妊娠小鼠β细胞中共同上调,妊娠时升高更显著。
- ENPP2通过LPA-Akt/mTOR通路促进β细胞增殖并抑制凋亡。
- Enpp2敲除小鼠高脂饮食下β细胞代偿不足,提示其关键作用。
核心结论
- ENPP2可能是肥胖期间β细胞代偿的关键调节因子,调节其水平或可成为减缓糖尿病β细胞恶化的潜在治疗靶点。
研究设计与样本
- 研究使用饮食诱导肥胖小鼠和妊娠小鼠的胰岛细胞进行单细胞RNA-seq分析。
- 通过定量PCR和免疫荧光验证ENPP2的基因和蛋白表达水平。
- 在Min6 β细胞、全身Enpp2敲除小鼠和β细胞Enpp2过表达转基因小鼠中采用功能获得和功能缺失方法研究ENPP2的作用。
主要发现
- 单细胞RNA-seq显示增殖是小鼠肥胖和妊娠期间β细胞数量代偿的主要共同机制,且妊娠时增殖比肥胖时更明显。
- ENPP2在妊娠小鼠β细胞中升高最显著,在肥胖小鼠β细胞中中度升高。
- 在Min6 β细胞中过表达或敲低ENPP2表明ENPP2促进β细胞增殖、抑制凋亡并增强高糖刺激的胰岛素分泌。
- Enpp2-Tg小鼠体内验证了ENPP2的上述效应;高脂饮食喂养的Enpp2敲除小鼠中ENPP2缺乏导致肥胖期间β细胞代偿不足。
- ENPP2的促增殖作用通过LPA受体2介导的LPA-Akt/mTOR信号通路实现;ENPP2在小鼠糖尿病模型和2型糖尿病参与者中表达较非糖尿病对照组降低;ENPP2由雌二醇和孕酮协同上调。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: We aimed to identify key molecules that can moderately enhance the compensatory capacity of beta cells during obesity. METHODS: Single-cell RNA-seq was used to profile the RNA expression of islet cells from diet-induced obese mice and pregnant mice. The gene and protein expression levels of ectonucleotide pyrophosphatase/phosphodiesterase 2 (ENPP2) were verified by quantitative PCR and immunofluorescence, respectively. The roles of ENPP2 were investigated using gain-of-function and loss-of-function approaches in Min6 beta cells, global Enpp2-knockout mice and beta cell Enpp2-overexpressing transgenic (Enpp2-Tg) mice. RESULTS: Using single-cell RNA-seq, we demonstrated that proliferation is the primary and common mechanism for compensating for beta cell numbers during both mouse obesity and pregnancy, with proliferation being more pronounced in pregnancy than in obesity. Additionally, many differentially expressed genes were co-regulated in both conditions. Among these, the pro-proliferative phosphodiesterase ENPP2 showed the highest increase in beta cells of pregnant mice and a moderate increase in beta cells of obese mice. Overexpression or knockdown of ENPP2 in Min6 beta cells revealed that ENPP2 promoted beta cell proliferation, inhibited apoptosis and enhanced high-glucose-stimulated insulin secretion. These effects of ENPP2 were further validated in vivo using Enpp2-Tg mice. In Enpp2-knockout mice fed a high-fat diet, the deficiency of ENPP2 resulted in insufficient compensation of beta cells during obesity. The pro-proliferative role of ENPP2 in beta cells was mediated through the lysophosphatidic acid (LPA)-Akt/mammalian target of rapamycin (mTOR) signalling pathway via LPA receptor 2. However, the expression of ENPP2 was reduced in the mouse model of diabetes and in human participants with type 2 diabetes compared with non-diabetic control groups. Furthermore, ENPP2 was co-upregulated by a synergy of oestradiol and progesterone. CONCLUSIONS/INTERPRETATION: ENPP2 may serve as a key regulator in beta cell compensation during obesity, and modulating its levels in beta cells could be a potential therapeutic target for mitigating beta cell deterioration in diabetes.
引用
- Zhou Y, Zeng Y, Chen Y, et al. Phosphodiesterase ENPP2, which is co-upregulated in obese and pregnant mice, is essential for islet beta cell compensation during obesity. Diabetologia. 2025. PMID: 41454014. doi:10.1007/s00125-025-06639-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。